These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24127192)

  • 1. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Burneo JG; Escalaya AL
    Neurology; 2013 Oct; 81(16):1474. PubMed ID: 24127192
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Sethi NK
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278969
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gonzalez-Duarte A
    Neurology; 2013 Oct; 81(16):1474-5. PubMed ID: 24278968
    [No Abstract]   [Full Text] [Related]  

  • 4. Author response.
    Baird RA; Wiebe S; Zunt JR; Halperin JJ; Roos KL
    Neurology; 2013 Oct; 81(16):1475-6. PubMed ID: 24278970
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence-based guideline: treatment of parenchymal neurocysticercosis: report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Baird RA; Wiebe S; Zunt JR; Halperin JJ; Gronseth G; Roos KL
    Neurology; 2013 Apr; 80(15):1424-9. PubMed ID: 23568997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocysticercosis--is the elimination of parasites beneficial?
    Sotelo J
    N Engl J Med; 2004 Jan; 350(3):280-2. PubMed ID: 14724309
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurocysticercosis with Diplopia Responds Well to Albendazole.
    Sato A; Nakamura I; Fujita H; Fukushima S; Mizuno Y; Fujii T; Matsumoto T
    Intern Med; 2016; 55(9):1219-22. PubMed ID: 27150884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of antiparasitic treatment for cerebral cysticercosis.
    Rojas-Flores I
    N Engl J Med; 2004 Apr; 350(16):1686-7; author reply 1686-7. PubMed ID: 15084706
    [No Abstract]   [Full Text] [Related]  

  • 9. Tapeworms and seizures--treatment and prevention.
    Maguire JH
    N Engl J Med; 2004 Jan; 350(3):215-7. PubMed ID: 14724299
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in computed tomogram in cerebral parenchymal cysticercosis treated with albendazole].
    Zhao S; Xu K
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(6):390-3. PubMed ID: 12563746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of antiparasitic treatment for cerebral cysticercosis.
    Kumar S
    N Engl J Med; 2004 Apr; 350(16):1686-7; author reply 1686-7. PubMed ID: 15088324
    [No Abstract]   [Full Text] [Related]  

  • 12. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Subcommittee of the American Academy of Neurology.
    Edlow JA
    Neurology; 2011 Jun; 76(23):2036; author reply 2038. PubMed ID: 21793246
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging of neurocysticercosis.
    Castillo M
    Semin Roentgenol; 2004 Oct; 39(4):465-73. PubMed ID: 15526530
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Practice parameter: assessing patients in a neurology practice for risk of falls (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Bruce BB; Biousse V; Newman NJ
    Neurology; 2009 Jan; 72(4):382; author reply 382-3. PubMed ID: 19180681
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.
    Singhi P; Jain V; Khandelwal N
    J Child Neurol; 2004 May; 19(5):323-7. PubMed ID: 15224704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amaurosis fugax caused by neurocysticercosis.
    Singhi P; Saini AG; Sankhyan N
    Pediatr Infect Dis J; 2014 Apr; 33(4):427. PubMed ID: 24632665
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurocysticercosis in children: clinical characteristics and outcome.
    Talukdar B; Saxena A; Popli VK; Choudhury V
    Ann Trop Paediatr; 2002 Dec; 22(4):333-9. PubMed ID: 12530283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.
    Montgomery MA; Ramos M; Kelvin EA; Carpio A; Jaramillo A; Hauser WA; Zhang H
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):781-788. PubMed ID: 31433058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality improvement in neurology: amyotrophic lateral sclerosis quality measures. Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.
    Miller RG; Brooks BR; Swain-Eng RJ; Basner RC; Carter GT; Casey P; Cohen AB; Dubinsky R; Forshew D; Jackson CE; Kasarskis E; Procaccini NJ; Sanjak M; Tolin FP
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):165-8. PubMed ID: 24707820
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.